Logo Prima Biomed

Welcome to the Newsroom

04 August 2015

Notice under Section 708A(5)(e) Corporations Act


In relation to the ordinary share issuances detailed in the Appendix 3B released today and on 30th July 2015, Prima BioMed Ltd (“the Company”) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:

1. the abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;